Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

405
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
405
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Purpose of Health Records II01:19

Purpose of Health Records II

997
Health records serve various essential purposes in the healthcare system. Here are some key purposes:
997
Purpose of Health Records I01:11

Purpose of Health Records I

1.3K
The vital purpose of health records is to provide a complete and accurate account of a patient's medical history, including communication, diagnostic and therapeutic orders, care planning, research, and quality review.
Here's a breakdown of how health records serve these purposes:
1.3K
Relative Risk01:12

Relative Risk

259
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
259
Hazard Ratio01:12

Hazard Ratio

173
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
173

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAMMAL - Molecular Aligned Multi-Modal Architecture and Language for biomedical discovery.

npj drug discovery·2026
Same author

Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes.

Nature medicine·2026
Same author

Generation of Automated Nephrometry Scores Through Direct Prediction of Each Component.

Urology·2026
Same author

Network-based prediction and real-world patient data observation identify doxycycline as a repurposable drug in Alzheimer's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation.

Alzheimer's & dementia (New York, N. Y.)·2025
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Sensitivity Analyses of a Scoring System for a Contraception Decision Aid.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Improving electronic health record processing of large language models via retrieval-augmented generation: A case study on dietary supplements.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Developing a User-Centered Mobile Application Prototype: Bridging Lower-Limb Fracture Care from Skilled Nursing Facility and Back to the Community.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

KERAP: A Knowledge-Enhanced Reasoning Approach for Accurate Zero-shot Diagnosis Prediction Using Multi-agent LLMs.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Automating Adjudication of Cardiovascular Events Using Large Language Models.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same journal

Predictive Factors and State-Level Barriers to Postpartum Birth Control Usage in the United States: Insights from PRAMS Phase 8.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment.

Michal Chorev1, Vesna Barros1,2, Adam Spiro1

  • 1IBM Research, Haifa, Israel.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|May 2, 2023
PubMed
Summary
This summary is machine-generated.

This study developed a personalized breast cancer (BC) risk model using electronic health records (EHR) and machine learning. The model shows improved performance over existing methods for predicting BC risk in women.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312

Related Experiment Videos

Last Updated: Jul 31, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Electronic health records (EHR) offer valuable data for developing breast cancer (BC) risk prediction models.
  • Accurate BC risk assessment is crucial for personalized screening and early detection.
  • Existing BC risk models have limitations in capturing individual-specific risk factors.

Purpose of the Study:

  • To develop and validate a personalized breast cancer risk model using machine learning and EHR data.
  • To assess the model's predictive performance compared to established BC risk models.
  • To identify novel clinical risk factors for breast cancer prediction.

Main Methods:

  • Retrospective analysis of EHR data from 13,786 Israeli and 1,695 American women.
  • Utilized 1,547 clinical features extracted from EHR, questionnaires, and radiologist reports.
  • Employed machine learning algorithms to build and evaluate the BC risk prediction model.

Main Results:

  • The developed personalized BC risk model demonstrated superior predictive performance.
  • The model's utility was validated across different datasets and sub-cohorts.
  • Identified novel risk factors that enhance BC prediction, even without imaging history.

Conclusions:

  • Personalized BC risk models based on EHR and machine learning can significantly improve risk prediction accuracy.
  • The model has potential for informing risk-based screening policies, especially for new patients.
  • The findings highlight the importance of integrating diverse clinical data for comprehensive BC risk assessment.